Indivina

Medroxyprogesterone acetate and estradiol valerate, the active ingredients in Indivina, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age.

GNH USA supplies Indivina as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indivina is a combined oral contraceptive that acts on the reproductive hormone pathway to prevent pregnancy.

Contraception: Prevents pregnancy by inhibiting ovulation and altering cervical mucus. Menstrual regulation: Provides more predictable menstrual cycles and reduces dysmenorrhea. Acne management: Improves moderate acne through hormonal regulation.

Indivina may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset often occurring early in treatment. - Headache: transient tension-type headaches. - Breast tenderness: swelling or discomfort of the breasts. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional fluctuations. - Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects: - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Stroke: cerebrovascular accident, especially in high‑risk individuals. - Myocardial infarction: heart attack risk in susceptible patients. - Severe hypertension: sudden increase in blood pressure. - Liver disorders: jaundice or hepatic dysfunction. - Allergic reactions: rash, itching, or anaphylaxis.

Before prescribing Indivina, clinicians should consider several precautionary measures to ensure patient safety.

Assess thromboembolic risk: evaluate personal and family history of clotting disorders. Screen for hypertension: measure blood pressure prior to initiation. Evaluate liver function: check hepatic enzymes in patients with liver disease. Counsel about smoking: advise cessation, especially in women over 35. Missed pill guidance: provide instructions for managing skipped doses. Store at ambient temperature: keep tablets in original packaging, protect from moisture and light.

Indivina can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Rifampin (potent CYP3A4 inducer) reduces contraceptive efficacy. - St. John’s wort (herbal CYP3A4 inducer) may lower hormone levels. - Certain antiepileptics (e.g., carbamazepine) decrease contraceptive effect. - HIV protease inhibitors (e.g., ritonavir) may increase hormone concentrations. - Griseofulvin (antifungal) reduces oral contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Ketoconazole (strong CYP3A4 inhibitor) may increase hormone levels. - Erythromycin (macrolide antibiotic) can raise plasma concentrations. - SSRIs (e.g., fluoxetine) may affect metabolism modestly. - NSAIDs (e.g., ibuprofen) may increase risk of hypertension. - Diuretics (e.g., thiazides) may affect electrolyte balance.